Matinas BioPharma Holdings (MTNB) Beginning Cash Balance (2013)

Matinas BioPharma Holdings (MTNB) reported Beginning Cash Balance of $11250.0 for Q2 2013, down 12.45% quarter-over-quarter from $12850.0 in Q1 2013.

Matinas BioPharma Holdings (MTNB) Beginning Cash Balance (2013) Analysis & Trends

Matinas BioPharma Holdings (MTNB) has 1 years of Beginning Cash Balance data on file, last reported at $11250.0 in Q2 2013.

Beginning Cash Balance for Q2 2013 came in at $11250.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2014 was $11250.0 (changed N/A YoY), and the FY2013 annual result was $24100.0, changed N/A from the prior year.
Beginning Cash Balance fell to $11250.0 in Q2 2013 per MTNB's latest filing, from $12850.0 in the prior quarter.
Over five years, Beginning Cash Balance peaked at $12850.0 in Q1 2013 and troughed at $11250.0 in Q2 2013.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn
9	Abivax	91.96 Bn	91.96 Bn	-
10	Matinas BioPharma Holdings	4.60 Mn	2.15 Mn	-

Download Data